pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

44 catalysts · 21 grant · 9 device pma · 6 device 510k · 5 recall · 2 approval · 1 device recall

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 16 catalysts2026-08-12: 19 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 20 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 8 catalysts2026-11-03: 17 catalysts2026-11-04: 22 catalysts2026-11-05: 36 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-02-04×to 2026-02-04×clear all
type
  • grant21
  • device pma9
  • device 510k6
  • recall5
  • approval2
  • device recall1
therapy area

no tagged catalysts yet

Week of Feb 2, 2026

44
›Feb 4, 2026approval188d agoATROPINE SULFATE — FDA approvalATROPINE SULFATE

Sponsor: ACCORD HLTHCARE. Form: SOLUTION. Route: INTRAVENOUS

full page →ATROPINE SULFATE →fda approvals ↗
›Feb 4, 2026approval188d agoCARBOPLATIN — FDA approvalOncotelic Therapeutics, Inc.

Sponsor: QILU PHARM HAINAN. Form: INJECTABLE. Route: INTRAVENOUS

full page →fda approvals ↗
›Feb 4, 2026recall188d agoHaleon US Holdings LLC recall (Cls III)

parodontax (cetylpyridinium chloride)ACTIVE GUM HEALTH, Mouthwash, Mint. Net Wt 16.9 FL OZ (500 mL), Distributed by Haleon, Warren, NJ 07059. NDC 0135-0651-02 — Reason: Labeling: Incorrect or Missing Lot and/or Exp Date: Potential for missing or illegible lot and expiration date coding on the bottles. — Status: Ongoing

full page →fda recalls ↗
›Feb 4, 2026recall188d agoBaxter Healthcare Corporation recall (Cls II)Baxter Healthcare Corp

Sterile Water for Irrigation, 250 mL, Single-Dose Plastic Bottle, Rx Only, Baxter Healthcare Corporation Deerfield, IL 60015 NDC: 0338-0004-02. — Reason: Presence of particulate matter: plastic particles from the bottle rim were observed floating into the solution — Status: Ongoing

full page →fda recalls ↗
›Feb 4, 2026recall188d agoNOVADOZ PHARMACEUTICALS LLC recall (Cls III)Novadoz Pharmaceuticals LLC

Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc., Piscataway, NJ 08854, Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854, NDC 72205-070-72 — Reason: Failed Impurities/Degradation Specifications — Status: Ongoing

full page →fda recalls ↗
›Feb 4, 2026recall188d agoGreenstone Llc recall (Cls II)Greenstone LLC

methylprednisolone tablets, USP Dosepak, 4 mg, 1 Blister Card per Carton containing 21 Tablets, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977. NDC 59762-4440-2 — Reason: Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil. — Status: Ongoing

full page →fda recalls ↗
›Feb 4, 2026recall188d agoSato Pharmaceutical Co., Ltd recall (Cls II)TAKEDA PHARMACEUTICAL CO LTD

INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and simethicone), 75-count bottle, Manufactured by: Sato Pharmaceutical Co., Ltd., NDC 49873-402-01 — Reason: Failed Disintegration Specifications: above the time expected. — Status: Ongoing

full page →fda recalls ↗
›Feb 4, 2026device 510k188d agoOrthosoft Inc. (d/b/a) Zimmer CAS — Signature™ ONE System (510k cleared)

Product code: QHE. Advisory committee: Orthopedic. Type: Special

full page →fda device 510k ↗
›Feb 4, 2026device 510k188d agoSpinal Elements, Inc. — Luna® Ti Interbody Fusion System (510k cleared)

Product code: MAX. Advisory committee: Orthopedic. Type: Traditional

full page →fda device 510k ↗
›Feb 4, 2026device 510k188d agoBard Peripheral Vascular, Inc. — UltraScore™ Focused Force PTA Balloon (510k cleared)

Product code: PNO. Advisory committee: Cardiovascular. Type: Special

full page →fda device 510k ↗
›Feb 4, 2026device 510k188d agoZimmer, Inc. — G7® Revision Acetabular System (510k cleared)

Product code: LPH. Advisory committee: Orthopedic. Type: Traditional

full page →fda device 510k ↗
›Feb 4, 2026device 510k188d agoYadu Medical (Henan) Co., Ltd. — Henan Yadu Level 4 Surgical Gowns (Reinforced) (510k cleared)

Product code: FYA. Advisory committee: General, Plastic Surgery. Type: Traditional

full page →fda device 510k ↗
›Feb 4, 2026device 510k188d agoEvolution Spine — E3D™-C Interbody System (510k cleared)

Product code: OVE. Advisory committee: Orthopedic. Type: Special

full page →fda device 510k ↗
›Feb 4, 2026device pma188d agoInstylla, Inc. — Embrace™ Hydrogel Embolic System (PMA supplement)

Supplement type: 30-Day Notice. Product code: QVG. Advisory committee: CV. Decision: OK30

full page →fda device pma ↗
›Feb 4, 2026device pma188d agoMedinol, Ltd. — EluNIR™ Ridaforolimus Eluting Coronary Stent System (PMA supplement)IGC Pharma, Inc.

Supplement type: 30-Day Notice. Product code: NIQ. Advisory committee: CV. Decision: OK30

full page →fda device pma ↗
›Feb 4, 2026device pma188d agoMentor Corp. — MENTOR™ MemoryGel™ Breast Implants (PMA supplement)

Supplement type: 30-Day Notice. Product code: FTR. Advisory committee: SU. Decision: OK30

full page →fda device pma ↗
›Feb 4, 2026device pma188d agoMentor Worldwide, LLC — MENTOR™ MemoryShape™ Breast Implants (PMA supplement)

Supplement type: 30-Day Notice. Product code: FTR. Advisory committee: SU. Decision: OK30

full page →fda device pma ↗
›Feb 4, 2026device pma188d agoMentor Worldwide, LLC — MENTOR™ Saline-Filled and SPECTRUM™ Breast Implants (PMA supplement)Revalesio Corp

Supplement type: 30-Day Notice. Product code: FWM. Advisory committee: SU. Decision: OK30

full page →fda device pma ↗
›Feb 4, 2026device pma188d agoGuardant Health, Inc. — Shield (PMA supplement)Guardant Health, Inc.

Supplement type: 30-Day Notice. Product code: PHP. Advisory committee: MG. Decision: OK30

full page →fda device pma ↗
›Feb 4, 2026device pma188d agoMedtronic, Inc. — Medtronic CoreValve™ Evolut™ PRO Transcatheter Aortic Valve (EVOLUTPRO-23-US, EVOLUTPRO-26-US, EVOLUTPRO-29-US); Medtron (PMA supplement)Medtronic plc

Supplement type: 30-Day Notice. Product code: NPT. Advisory committee: CV. Decision: OK30

full page →fda device pma ↗
›Feb 4, 2026device pma188d agoABBOTT MEDICAL — HeartMate 3 Left Ventricular Assist System (PMA supplement)

Supplement type: 30-Day Notice. Product code: DSQ. Advisory committee: CV. Decision: OK30

full page →fda device pma ↗
›Feb 4, 2026device pma188d agoMedtronic, Inc. — Avalus™ Bioprosthesis Model 400 (40019, 40021, 40023, 40025, 40027, 40029); Avalus™ Ultra Bioprosthesis Model 400 (400U1 (PMA supplement)Medtronic plc

Supplement type: 30-Day Notice. Product code: LWR. Advisory committee: CV. Decision: OK30

full page →fda device pma ↗
›Feb 4, 2026device recall188d agoDiagnostica Stago, Inc. device recall (Cls II)

Brand Name: STA Liatest Free Protein S Product Name: STA Liatest Free Protein S Model/Catalog Number (REF): 00516 Product Description: The STA¿ - Liatest¿ Free Protein S kits are intended for use on STA-R¿ and STA Compact¿ for the quantitative antigenic assay of free protein S in human citrated plasma by the immuno-turbidimetric method. Component: Not Applicable — Reason: The potential of out-of-range results and an underestimation of the free protein S level in normal patient plasmas. The defect only affects normal-range values. — Status: Ongoing

full page →fda device recalls ↗
›Feb 4, 2026grant188d agoUNIVERSITY OF CALIFORNIA, SAN DIEGO — Discovery and evolution of mammalian Serpins as host-encoded viral protease i...University of California San Diego

AI grant. $439,250. PI: Matthew Daugherty

full page →nih reporter ↗
›Feb 4, 2026grant188d agoDUKE UNIVERSITY — BCG-Mediated Immunotherapy Against BacteriaDuke University

AI grant. $610,124. PI: Soman N Abraham

full page →nih reporter ↗
›Feb 4, 2026grant188d agoUNIV OF MARYLAND, COLLEGE PARK — Longitudinal Mixed Methods Analysis of Risk and Protective Factors Influencin...

HD grant. $35,832. PI: Pond Ezra

full page →nih reporter ↗
›Feb 4, 2026grant188d agoTUFTS UNIVERSITY BOSTON — Characterization and treatment of an accelerated aging model of the olfactory...

DC grant. $779,636. PI: Brian Lin

full page →nih reporter ↗
›Feb 4, 2026grant188d agoNORTH CAROLINA AGRI & TECH ST UNIV — Biomarkers for Whole Grain Intake and Cardiometabolic Health

DK grant. $765,558. PI: Shengmin Sang

full page →nih reporter ↗
›Feb 4, 2026grant188d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — A rationally designed phage cocktail to treat MDR P. aeruginosa infections

AI grant. $437,250. PI: Ryan K Shields

full page →nih reporter ↗
›Feb 4, 2026grant188d agoCHILDREN'S HOSP OF PHILADELPHIA — Cul5 dampens cytokine sensing in Type II lymphocytes to prevent allergic airw...

AI grant. $670,017. PI: Paula Maria Oliver

full page →nih reporter ↗
›Feb 4, 2026grant188d agoSTATE UNIVERSITY NEW YORK STONY BROOK — Haemophysalis Longicornis Capacity to Acquire and Transmit Babesia Microti

AI grant. $436,605. PI: Charles Kyriakos Vorkas

full page →nih reporter ↗
›Feb 4, 2026grant188d agoMAYO CLINIC ROCHESTER — C. albicans Induced Immune Skewing in Early LifeMayo Clinic

AI grant. $443,850. PI: Kathryn A Knoop

full page →nih reporter ↗
›Feb 4, 2026grant188d agoUNIV OF NORTH CAROLINA CHAPEL HILL — Translation Regulation during Human Cytomegalovirus Infection

AI grant. $553,779. PI: Nathaniel J Moorman

full page →nih reporter ↗
›Feb 4, 2026grant188d agoNORTHWESTERN UNIVERSITY AT CHICAGO — Ubiquitin Ligase TRIM39 Control of Zika Virus InfectionNorthwestern University

AI grant. $200,000. PI: CURT M HORVATH

full page →nih reporter ↗
›Feb 4, 2026grant188d agoCOLUMBIA UNIV NEW YORK MORNINGSIDE — The assembly of R-bodies in Pseudomonas aeruginosa and their contribution to ...

AI grant. $560,455. PI: Lars Dietrich

full page →nih reporter ↗
›Feb 4, 2026grant188d agoCORNELL UNIVERSITY — Post-transcriptional regulation of pathogenic Th17 function

AI grant. $2,800,280. PI: Mandy J McGeachy

full page →nih reporter ↗
›Feb 4, 2026grant188d agoCASE WESTERN RESERVE UNIVERSITY — An Atlas of Bacterial Physiology in the Human Oral CavityCase Western Reserve University

DE grant. $340,149. PI: Gina Lewin

full page →nih reporter ↗
›Feb 4, 2026grant188d agoMASSACHUSETTS GENERAL HOSPITAL — Audible diabetesRx: An audio-based digital tool to address health literacy ba...Massachusetts General Hospital

DK grant. $123,750. PI: Jacqueline Anne Seiglie

full page →nih reporter ↗
›Feb 4, 2026grant188d agoUNIVERSITY OF COLORADO DENVER — Defining the role of antigen-specific T cell responses in NASHUniversity of Colorado Denver

DK grant. $791,520. PI: Matthew A Burchill

full page →nih reporter ↗
›Feb 4, 2026grant188d agoUNIVERSITY OF IOWA — Explaining the contagious nature of measles virusUniversity of Iowa

AI grant. $791,990. PI: PATRICK L SINN

full page →nih reporter ↗
›Feb 4, 2026grant188d agoICAHN SCHOOL OF MEDICINE AT MOUNT SINAI — Fab-drug conjugates in transplant

AI grant. $462,000. PI: Miguel Fribourg

full page →nih reporter ↗
›Feb 4, 2026grant188d agoNEW YORK UNIVERSITY SCHOOL OF MEDICINE — Intestinal Programming of Gut-Associated Germinal CentersNew York University

AI grant. $791,797. PI: Carla Rose Nowosad

full page →nih reporter ↗
›Feb 4, 2026grant188d agoWASHINGTON UNIVERSITY — Exploring undefined roles of Calcineurin in restriction of autophagy-mediated...

AI grant. $427,625. PI: Takeshi Egawa

full page →nih reporter ↗
›Feb 4, 2026grant188d agoWASHINGTON UNIVERSITY — Defining the cellular basis of neurological dysfunction in models of ALG8 Con...

NS grant. $37,249. PI: Haley Jetter

full page →nih reporter ↗
$IGC0.2670+0.41%
$TAK17.55+0.57%
$OTLC0.0373-8.80%
$MDT89.41+2.58%
$GH131.78+2.07%
$MDT89.41+2.58%